Next 10 |
home / stock / ptgef / ptgef news
-- Company to advance three clinical-stage programs in pipeline -- -- Portage has received approval and is preparing for NASDAQ listing -- Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") today annou...
New York, New York--(Newsfile Corp. - December 1, 2020) - Portage Biotech (OTC Pink: PTGEF) (CSE: PBT.U) is an emerging biotechnology company developing an immunotherapy focused pipeline to treat a broad range of cancers. Unlike most biotechs though, Portage focuses on combining its own techno...
Toronto, Ontario--(Newsfile Corp. - October 16, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that the Company has filed its interim financial statements and related management's discussion and analysis for the three-month period ending June...
Toronto, Ontario--(Newsfile Corp. - October 13, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") wishes to announce that it has issued 375,014 common shares at a deemed price of US$6.64 per common share and 72,291 common share purchase warrants exercis...
Toronto, Ontario--(Newsfile Corp. - August 28, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") wishes to announce that it will be utilizing the extension period provided under Ontario Instrument 51-505 - Temporary Exemption from Certain Corporate ...
Reflecting significant strengthening of Company's fundamentals Pipeline progressing: anticipate 3 clinical programs by year end Financial resources enable accelerated development and opportunistic value creation Toronto, Ontario--(Newsfile Corp. - August 24, 2020) - Portage Biotech I...
Toronto, Ontario--(Newsfile Corp. - July 28, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that it is utilizing the extension period provided under Ontario Instrument 51-505 - Temporary Exemption from Certain Corporate Finance Requirements w...
TORONTO , June 26, 2020 /PRNewswire/ - Portage Biotech Inc. (CSE: PBT.U) (OTC Markets: PTGEF) ("Portage" or the "Company") is very pleased to announce the results of its annual meeting of shareholders (the "Meeting") held on June 25, 2020 . Over 70% of all issued and outstanding com...
Accelerates pipeline development and execution Enables new opportunistic value creation Anticipate 3 clinical programs by year end TORONTO , June 16, 2020 /PRNewswire/ - Portage Biotech Inc. (CSE: PBT.U) (OTC Markets: PTGEF) ("Portage" or the "Company") is very pleased to announce...
TORONTO , June 3, 2020 /PRNewswire/ - Portage Biotech Inc. (CSE: PBT.U) (OTC-Markets: PTGEF) ("Portage" or the "Corporation") wishes to announce that, further to its news release dated May 25, 2020 , the Corporation's common shares will commence trading on a one hundred (100) o...
News, Short Squeeze, Breakout and More Instantly...
Portage Biotech Company Name:
PTGEF Stock Symbol:
OTCMKTS Market:
-- Company to advance three clinical-stage programs in pipeline -- -- Portage has received approval and is preparing for NASDAQ listing -- Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") today annou...
New York, New York--(Newsfile Corp. - December 1, 2020) - Portage Biotech (OTC Pink: PTGEF) (CSE: PBT.U) is an emerging biotechnology company developing an immunotherapy focused pipeline to treat a broad range of cancers. Unlike most biotechs though, Portage focuses on combining its own techno...
Toronto, Ontario--(Newsfile Corp. - October 16, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that the Company has filed its interim financial statements and related management's discussion and analysis for the three-month period ending June...